Compounds > methylprednisolone

methylprednisolone and Hypertension, Malignant

methylprednisolone has been researched along with Hypertension, Malignant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukase, S; Goto, T; Saito, M; Suzuki, M; Yokoyama, K1
DEGRAFF, AC; FISCH, S; HOFF, HR; SINGER, MM1

Other Studies

2 other study(ies) available for methylprednisolone and Hypertension, Malignant

ArticleYear
[IgA nephropathy with malignant hypertension].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2002, Aug-10, Volume: 91, Issue:8

    Topics: Adult; Female; Glomerulonephritis, IGA; Humans; Hypertension, Malignant; Methylprednisolone; Pulse Therapy, Drug; Tonsillectomy; Treatment Outcome

2002
RED BLOOD CELL POTASSIUM; THERAPEUTIC IMPLICATIONS.
    JAMA, 1964, Jan-04, Volume: 187

    Topics: Anemia; Anemia, Hypochromic; Blood Platelets; Digitalis Glycosides; Diuretics; Erythrocytes; Fludrocortisone; Heart Failure; Hematocrit; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Malignant; Insulin; Methylprednisolone; Potassium; Triamterene

1964